Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Are Biotransformation Studies of Therapeutic Proteins Needed? Scientific Considerations and Technical Challenges
Simone Schadt, Simon Hauri, Filipe Lopes, et al.
Drug Metabolism and Disposition (2019) Vol. 47, Iss. 12, pp. 1443-1456
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Characterization of Antibody–Drug Conjugate Pharmacokinetics and in Vivo Biotransformation Using Quantitative Intact LC-HRMS and Surrogate Analyte LC-MRM
Yue Huang, Si Mou, Yadi Wang, et al.
Analytical Chemistry (2021) Vol. 93, Iss. 15, pp. 6135-6144
Open Access | Times Cited: 37
Extensive Biotransformation Profiling of AZD8205, an Anti-B7-H4 Antibody-Drug Conjugate, Elucidates Pathways Underlying its Stability In Vivo
Yue Huang, Hui Yin Tan, Jiaqi Yuan, et al.
(2024)
Open Access | Times Cited: 5
Extensive Biotransformation Profiling of AZD8205, an Anti-B7-H4 Antibody-Drug Conjugate, Elucidates Pathways Underlying Its Stability In Vivo
Yue Huang, Hui Yin Tan, Jiaqi Yuan, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 42, pp. 16525-16533
Open Access | Times Cited: 5
Radiolabelling small and biomolecules for tracking and monitoring
Martin R. Edelmann
RSC Advances (2022) Vol. 12, Iss. 50, pp. 32383-32400
Open Access | Times Cited: 20
A novel in vitro serum stability assay for antibody therapeutics incorporating internal standards
Yihan Li, Rosendo Villafuerte-Vega, Vikram M. Shenoy, et al.
mAbs (2025) Vol. 17, Iss. 1
Open Access
Intact Protein Mass Spectrometry for Therapeutic Protein Quantitation, Pharmacokinetics, and Biotransformation in Preclinical and Clinical Studies: An Industry Perspective
John F. Kellie, John C. Tran, Wenying Jian, et al.
Journal of the American Society for Mass Spectrometry (2020) Vol. 32, Iss. 8, pp. 1886-1900
Closed Access | Times Cited: 29
Unusual Biotransformation Reactions of Drugs and Drug Candidates
Emre M. Isin
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 4, pp. 413-426
Open Access | Times Cited: 9
Comparative study of trastuzumab modification analysis using mono/multi-epitope affinity technology with LC-QTOF-MS
Chengyi Zuo, Jingwei Zhou, Sumin Bian, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 14, Iss. 11, pp. 101015-101015
Open Access | Times Cited: 3
Developability considerations for bispecific and multispecific antibodies
Alaa Amash, Gesa Volkers, Patrick Farber, et al.
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Analytical and pharmacological consequences of the in vivo deamidation of trastuzumab and pertuzumab
Peter Bults, Anna van der Voort, Coby Meijer, et al.
Analytical and Bioanalytical Chemistry (2022) Vol. 414, Iss. 4, pp. 1513-1524
Closed Access | Times Cited: 14
Extensive Biotransformation Profiling of AZD8205, an Anti-B7-H4 Antibody-Drug Conjugate, Elucidates Pathways Underlying its Stability In Vivo
Yue Huang, Hui Yin Tan, Jiaqi Yuan, et al.
(2024)
Open Access | Times Cited: 2
A general perspective for the conduct of radiolabelled distribution, metabolism, and excretion studies for antibody-drug conjugates
Bettina Rudolph, John A. Davis, Dominik Hainzl, et al.
Xenobiotica (2024) Vol. 54, Iss. 8, pp. 521-532
Closed Access | Times Cited: 2
Detailed Structural Elucidation of Antibody-Drug Conjugate Biotransformation Species Using High Resolution Multiple Reaction Monitoring Mass Spectrometry with Orthogonal Dissociation Methods
Junyan Yang, Hui Yin Tan, Jiaqi Yuan, et al.
ACS Pharmacology & Translational Science (2024) Vol. 8, Iss. 1, pp. 113-123
Open Access | Times Cited: 2
A Cross Company Perspective on the Assessment of Therapeutic Protein Biotransformation
Markus Walles, Michael J. Berna, Wenying Jian, et al.
Drug Metabolism and Disposition (2022) Vol. 50, Iss. 6, pp. 846-857
Open Access | Times Cited: 12
Antibody Subunit LC-MS Analysis for Pharmacokinetic and Biotransformation Determination from In-Life Studies for Complex Biotherapeutics
John F. Kellie, Kristen E. Pannullo, Yinghe Li, et al.
Analytical Chemistry (2020) Vol. 92, Iss. 12, pp. 8268-8277
Closed Access | Times Cited: 17
Bioanalytical Challenges in Support of Complex Modalities of Antibody-Based Therapeutics
Liang Zhu, Jim Glick, Jimmy Flarakos
The AAPS Journal (2020) Vol. 22, Iss. 6
Closed Access | Times Cited: 16
Immunoaffinity Capillary Electrophoresis in the Era of Proteoforms, Liquid Biopsy and Preventive Medicine: A Potential Impact in the Diagnosis and Monitoring of Disease Progression
Norberto A. Guzman, Daniel E. Guzman
Biomolecules (2021) Vol. 11, Iss. 10, pp. 1443-1443
Open Access | Times Cited: 13
Analytical Challenges Assessing Protein Aggregation and Fragmentation Under Physiologic Conditions
Joachim Schuster, Hanns‐Christian Mahler, Susanne Joerg, et al.
Journal of Pharmaceutical Sciences (2021) Vol. 110, Iss. 9, pp. 3103-3110
Closed Access | Times Cited: 11
Analytical tools for the characterization of deamidation in monoclonal antibodies
Baubek Spanov, Natalia Govorukhina, Nico C. van de Merbel, et al.
Journal of Chromatography Open (2021) Vol. 2, pp. 100025-100025
Open Access | Times Cited: 11
Direct bioanalysis or indirect calculation of target engagement and free drug exposure: do we apply double standards?
Gregor Jordan, Roland F. Staack
Bioanalysis (2023) Vol. 15, Iss. 1, pp. 5-16
Open Access | Times Cited: 4
Multiepitope recognition technology promotes the in-depth analysis of antibody‒drug conjugates
Yutian Lei, Yuan Shen, Feng Chen, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 11, pp. 4962-4976
Open Access | Times Cited: 1
In vitro/in vivo degradation analysis of trastuzumab by combining specific capture on HER2 mimotope peptide modified material and LC-QTOF-MS
Lu Li, Xiao Liu, Chengyi Zuo, et al.
Analytica Chimica Acta (2022) Vol. 1225, pp. 340199-340199
Open Access | Times Cited: 7
Bioanalysis in the Age of New Drug Modalities
Jing Shi, Xuesong Chen, Jianbo Diao, et al.
The AAPS Journal (2021) Vol. 23, Iss. 3
Open Access | Times Cited: 9
Challenges of non-clinical safety testing for biologics: A Report of the 9th BioSafe European Annual General Membership Meeting
Thomas Kissner, Guenter Blaich, Andreas Baumann, et al.
mAbs (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Impact of Organ Impairment on the Pharmacokinetics of Therapeutic Peptides and Proteins
Elimika Pfuma Fletcher, Martina Sahre, Yuen Yi Hon, et al.
The AAPS Journal (2023) Vol. 25, Iss. 4
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top